Table 2 Demographic and clinical characteristics of all patients included in the study
DAW group | DW group | P value | |
|---|---|---|---|
N = 21 | N = 24 | ||
Age, years | 48.6 (22-81) | 46.8 (22-71) | 0.688 |
Male to female | 17:4 | 20:4 | 1.000 |
HBV positivitya | 16 (76.2%) | 21 (87.5%) | 0.549 |
Tumor location | 0.607 | ||
Left lobe | 5 (23.8%) | 6 (25%) | |
Right lobe | 12 (57.1% | 15 (62.5%) | |
Both left and right lobe | 4 (19.1%) | 3 (12.5%) | |
Child-Pugh classificationa | 0.551 | ||
A | 20 (95.2%) | 22 (91.7%) | |
B | 1 (4.8%) | 2 (8.3%) | |
C | 0 | 0 | |
Pre-operation TACEa | 0 | 3 (12.5%) | 0.236 |
AST, IU/L | 70.7 (29–160) | 78.6 (22–347) | 0.795 |
ALT, IU/L | 47.8 (16–162) | 59.3 (26–152) | 0.507 |
AFP, IU/mL | 45,705.0 (1.14–225,046) | 32,254.8 (2.41–129,869) | 0.662 |
Tumor size, cm | 9.3 (4–20) | 8.3 (3–21.5) | 0.713 |
Tumor numbera | 0.127 | ||
Single | 16 (76.2%) | 21 (87.5%) | |
Multiple | 5 (23.8%) | 3 (12.5%) | |
Vascular invasiona | 12 (57.1%) | 15 (62.5%) | 0.714 |
Organ invasiona | 7 (33.3%) | 5 (20.8%) | 0.344 |
Liver cirrhosisa | 0.705 | ||
Yes | 3 (14.3%) | 5 (20.8%) | |
No | 18 (85.7%) | 19 (79.2%) |